| Name | Title | Contact Details |
|---|
Clarion Partners is a leading U.S. real estate investment manager. The Firm is headquartered in New York with a presence in major markets across the United States, as well as in São Paulo, Brazil, London, England and Mexico City. Our organization is built on a broad network of real estate professionals who bring knowledge of local markets to every investment decision. • Investments in high quality properties, typically from the five key property types: office, retail, industrial, multifamily residential and hotel • Broad range of real estate strategies across the risk/return spectrum: core, core-plus, value-add and opportunistic • $43.3 billion in total assets under management • 300+ institutional investors both domestic and international • Investment options in both fund and separate account formats • Expertise in equity and debt structures • 280+ employees • SEC-registered investment advisor • Distinguished investment manager with 35-year history We provide investors with long-term real estate solutions to support their investment objectives, mindful of our obligations of accountability, transparency and trust.
Morgan Creek Capital Management is a Chapel Hill, NC-based company in the Financial Services sector.
Central States Fund is a Des Plaines, IL-based company in the Financial Services sector.
A private real estate investment group designed to produce consistent, high-yield returns while providing security, stable growth, and cash flow.
Harris and Harris Group, Inc. builds transformative companies from disruptive science. We leverage our core scientific expertise to be FIRST in identifying new technology trends, in accessing high quality science and intellectual property, in building management teams and in executing on early-stage business growth. Our PROVEN team has the unique ability to identify and diligence the network of discoveries that come from understanding science at the intersection of different scientific disciplines, with biology as a focus. This places us at the center of the discoveries impacting some of the most important growth sectors of the economy, permitting us to build TRANSFORMATIVE companies. BIOLOGY+ is our distinctive approach. We define BIOLOGY+ as investments in interdisciplinary life science companies where biology innovation is intersecting with innovations in areas such as electronics, physics, materials science, chemistry, information technology, engineering and mathematics. We focus on this intersection because we believe interdisciplinary innovation will be required in order to address many of the life science challenges of the future.